A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes

The most common reasons for switching HIV-1 therapy in patients with virologic suppression are treatment regimen simplification and resolving tolerability issues. Single-pill regimens that include an integrase inhibitor are recommended options. A retrospective clinical audit was performed to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer, Pedro E, Bloch, Mark, Roth, Norman, Finlayson, Robert, Baker, David, Koh, Ken, Orth, David, Urbaityte, Rimgaile, Brown, Dannae, Drummond, Fraser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Audit Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794104/
https://www.ncbi.nlm.nih.gov/pubmed/28901212
http://dx.doi.org/10.1177/0956462417730474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794104/
https://www.ncbi.nlm.nih.gov/pubmed/28901212
http://dx.doi.org/10.1177/0956462417730474

Ejemplares similares